Frontiers in Immunology · 2018 · 33 citations · 40 references
Life SciencesImmunologyOncologyImmunotherapyTumor ImmunologyTumor MicroenvironmentImmune Cell InfiltrationNatural Killer Cell BiologyNatural Killer Cell FunctionNatural Killer Cell RegulationTumor Immune MicroenvironmentTumor Microenvironment ModulationAntibody-dependent Cell-mediated CytotoxicityAntibody-dependent Cellular CytotoxicityCetuximab TherapyEpidermal Growth Factor Receptor InhibitionImmune Evasion By TumorsImmunosuppressive MicroenvironmentNatural Killer Cell Receptor Nkg2dNkg2d-mediated Recognition
Mesenchymal stromal cells (MSC) present in the tumor microenvironment (usually named tumor-associated fibroblasts, TAF) can exert immunosuppressive effects on T and natural killer (NK) lymphocytes, favouring tumor immune escape. We have analyzed this mechanism in colorectal carcinoma (CRC) and found that co-culture of NK cells with TAF can prevent the IL2-mediated NKG2D upregulation. This leads to the impairment of NKG2D-mediated recognition of CRC cells, sparing the NK cell activation through DNAM1 or FcγRIIIA (CD16). In situ, TAF express detectable levels of epidermal growth factor receptor (EGFR); thus, the therapeutic anti-EGFR humanized antibody cetuximab can trigger the antibody dependent cellular cytotoxicity of TAF, through the engagement of FcγRIIIA on NK cells. Importantly, in the tumor we found a lymphoid infiltrate containing NKp46+CD3- NK cells, enriched in CD16+ cells. This population, sorted and cultured with IL2, could be triggered via CD16 and via NKG2D. Of note, ex-vivo NKp46+CD3- cells were able to kill autologous TAF; in vivo, this might represent a control mechanism to reduce TAF-mediated regulatory effect on NK cell function. Altogether, these findings suggest that MSC from the neoplastic mucosa (TAF) of CRC patients can down-regulate the immune cell recognition of CRC tumor cells. This immunosuppression can be relieved by the anti-EGFR antibody used in CRC immunotherapy.
40
Human mesenchymal stem cells modulate allogeneic immune cell responses
Sudeepta Aggarwal, Mark F. Pittenger · Blood · 2004 · 4.5K citations · Full text
Grazia Maria Spaggiari, Andrea Capobianco, S. Becchetti et al. · Blood · 2005 · 1K citations · Full text